Cargando…

Tumor invasion depth is a useful pathologic assessment for predicting outcomes in cervical squamous cell carcinoma after neoadjuvant radiotherapy

BACKGROUND: To evaluate whether tumor invasion depth can be a reliable and easily applicable pathologic assessment strategy to predict outcomes using surgically resected cervical squamous cell carcinoma specimens from patients who have received neoadjuvant radiotherapy (RT) or concurrent chemoradiot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Yang, Wang, Ning, Liu, Yixiong, Li, Xia, Fan, Linni, Li, Mingyang, Wang, Lu, Yu, Zhou, Yan, Qingguo, Guo, Ying, Guo, Shuangping, Wei, Lichun, Shi, Mei, Wang, Zhe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632273/ https://www.ncbi.nlm.nih.gov/pubmed/26537362 http://dx.doi.org/10.1186/s13000-015-0426-6

Ejemplares similares

Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma
por: Xu, Tianqi, et al.
Publicado: (2019)

Expression of RSK4, CD44 and MMP-9 is upregulated and positively correlated in metastatic ccRCC
por: Ma, Jing, et al.
Publicado: (2020)

Primary Astrocytic Tumours and Paired Recurrences have Similar Biological Features in IDH1, TP53 and TERTp Mutation and MGMT, ATRX Loss
por: Li, Xia, et al.
Publicado: (2017)

BRAF V600E mutation correlates with suppressive tumor immune microenvironment and reduced disease-free survival in Langerhans cell histiocytosis
por: Zeng, Kaixuan, et al.
Publicado: (2016)

MET-overexpressing myxofibrosarcoma frequently exhibit polysomy of chromosome 7 but not MET amplification, especially in high-grade cases: clinical and pathological review of 30 myxofibrosarcoma cases
por: Ma, Shirong, et al.
Publicado: (2018)

Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma
por: Li, Peifeng, et al.
Publicado: (2021)

Autophagy defects and related genetic variations in renal cell carcinoma with eosinophilic cytoplasmic inclusions
por: Yu, Zhou, et al.
Publicado: (2018)

Tumor Immune Microenvironment Components and Checkpoint Molecules in Anaplastic Variant of Diffuse Large B-Cell Lymphoma
por: Xu, Tianqi, et al.
Publicado: (2021)

CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma
por: Fan, Linni, et al.
Publicado: (2011)

Different pathologic responses to neoadjuvant anti-PD-1 in primary squamous lung cancer and regional lymph nodes
por: Ling, Yun, et al.
Publicado: (2020)

Predicting pathological complete response of neoadjuvant radiotherapy and targeted therapy for soft tissue sarcoma by whole-tumor texture analysis of multisequence MRI imaging
por: Miao, Lei, et al.
Publicado: (2022)

MicroRNA-142-5p contributes to Hashimoto’s thyroiditis by targeting CLDN1
por: Zhu, Jin, et al.
Publicado: (2016)

EWSR1::SMAD3-rearranged fibroblastic tumor: A case with twice recurrence and literature review
por: Yang, Li, et al.
Publicado: (2022)

Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma
por: Han, Weiming, et al.
Publicado: (2022)

Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma Incorporating Hematological Biomarkers
por: Wu, Yingjia, et al.
Publicado: (2021)

A noninvasive mucinous cystic neoplasm with intermediate-grade dysplasia of the pancreas and extensive squamous metaplasia: a case report with clinicopathological correlation
por: Li, Peifeng, et al.
Publicado: (2012)

Low expression of H3K27me3 is associated with poor prognosis in conventional chordoma
por: Wei, Jie, et al.
Publicado: (2022)

CT-based radiomic signatures for prediction of pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy
por: Yang, Zhining, et al.
Publicado: (2019)

Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma
por: An, Lingbo, et al.
Publicado: (2023)

Pathologic response and safety to neoadjuvant PD-1 inhibitors and chemotherapy in resectable squamous non-small-cell Lung cancer
por: Shi, Liang, et al.
Publicado: (2022)

Comparison of imaging-based gross tumor volume and pathological volume determined by whole-mount serial sections in primary cervical cancer
por: Zhang, Ying, et al.
Publicado: (2013)

Pathologic responses and surgical outcomes after neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma
por: Xu, Lei, et al.
Publicado: (2022)

Assessment of tumor depth in oral tongue squamous cell carcinoma with multiparametric MRI: correlation with pathology
por: Tang, Weiqing, et al.
Publicado: (2021)

PATHOLOGIC COMPLETE RESPONSE (YPT0 YPN0) AFTER CHEMOTHERAPY AND RADIOTHERAPY NEOADJUVANT FOLLOWED BY ESOPHAGECTOMY IN THE SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS
por: ANDREOLLO, Nelson Adami, et al.
Publicado: (2018)

Prediction Formula for Pathological Depth of Invasion From Clinical Depth of Invasion in Tongue Squamous Cell Carcinoma (SCC) Stage I/II Cases
por: Hamada, Mei, et al.
Publicado: (2023)

Pathological complete response after neoadjuvant treatment determines survival in esophageal squamous cell carcinoma patients (NEOCRTEC5010)
por: Shen, Jianfei, et al.
Publicado: (2021)

Neoadjuvant PD‐1 inhibitor combines with chemotherapy versus neoadjuvant chemotherapy in resectable squamous cell carcinoma of the lung
por: Feng, Yuan, et al.
Publicado: (2021)

A Comparison of Different Schemes of Neoadjuvant Chemotherapy Followed by Concurrent Chemotherapy and Radiotherapy for Locally Advanced Cervical Cancer: A Retrospective Study
por: Tian, Xue, et al.
Publicado: (2021)

Lymphocyte-monocyte ratio as a predictive marker for pathological complete response to neoadjuvant therapy in esophageal squamous cell carcinoma
por: Zhao, Kewei, et al.
Publicado: (2020)

Cervical small cell carcinoma frequently presented in multiple high risk HPV infection and often associated with other type of epithelial tumors
por: Li, Peifeng, et al.
Publicado: (2018)

Intensity-Modulated Radiotherapy versus Three-Dimensional Conformal Radiotherapy in Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: Comparison of Survival Outcomes and Toxicities
por: Chen, Nai-Bin, et al.
Publicado: (2020)

The Role of Radiotherapy for Patients with Unresectable Locally Advanced Breast Cancer following Neoadjuvant Systemic Therapy
por: Wang, Xiaofang, et al.
Publicado: (2023)

Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy
por: Li, Xinyan, et al.
Publicado: (2019)

Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
por: Huang, Ren-Wen, et al.
Publicado: (2014)

Effect of Lymph Node Count on Pathological Stage III Rectal Cancer with Preoperative Radiotherapy
por: Li, Qingguo, et al.
Publicado: (2015)

Comparison  of  efficacy, safety, and costs between neoadjuvant hypofractionated radiotherapy and conventionally fractionated radiotherapy for esophageal carcinoma
por: Lyu, Jiahua, et al.
Publicado: (2019)

An MRI‐based machine learning radiomics can predict short‐term response to neoadjuvant chemotherapy in patients with cervical squamous cell carcinoma: A multicenter study
por: Xin, Zhonghong, et al.
Publicado: (2023)

Predictive value of microvessel features for the clinical response to neoadjuvant chemotherapy in cervical squamous carcinoma and the associations with prognosis
por: Li, Weili, et al.
Publicado: (2021)

A Preoperative Nomogram for Predicting Chemoresistance to Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Squamous Carcinoma Treated with Radical Hysterectomy
por: Ou, Zhengjie, et al.
Publicado: (2021)

Optimal pathological response indicated better long-term outcome among patients with stage IB2 to IIB cervical cancer submitted to neoadjuvant chemotherapy
por: Huang, Kecheng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q1aonl6d2p56uq62tla944jejk